293 related articles for article (PubMed ID: 15214797)
21. Lead identification of conformationally restricted β-lactam type combretastatin analogues: synthesis, antiproliferative activity and tubulin targeting effects.
Carr M; Greene LM; Knox AJ; Lloyd DG; Zisterer DM; Meegan MJ
Eur J Med Chem; 2010 Dec; 45(12):5752-66. PubMed ID: 20933304
[TBL] [Abstract][Full Text] [Related]
22. Lyngbyastatin 1 and Ibu-epilyngbyastatin 1: synthesis, stereochemistry, and NMR line broadening.
Bai R; Bates RB; Hamel E; Moore RE; Nakkiew P; Pettit GR; Sufi BA
J Nat Prod; 2002 Dec; 65(12):1824-9. PubMed ID: 12502322
[TBL] [Abstract][Full Text] [Related]
23. Benzoylphenylurea sulfur analogues with potent antitumor activity.
Hallur G; Jimeno A; Dalrymple S; Zhu T; Jung MK; Hidalgo M; Isaacs JT; Sukumar S; Hamel E; Khan SR
J Med Chem; 2006 Apr; 49(7):2357-60. PubMed ID: 16570932
[TBL] [Abstract][Full Text] [Related]
24. Concise synthesis and structure-activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents.
Liou JP; Chang YL; Kuo FM; Chang CW; Tseng HY; Wang CC; Yang YN; Chang JY; Lee SJ; Hsieh HP
J Med Chem; 2004 Aug; 47(17):4247-57. PubMed ID: 15293996
[TBL] [Abstract][Full Text] [Related]
25. Arylthioindoles, potent inhibitors of tubulin polymerization.
De Martino G; La Regina G; Coluccia A; Edler MC; Barbera MC; Brancale A; Wilcox E; Hamel E; Artico M; Silvestri R
J Med Chem; 2004 Dec; 47(25):6120-3. PubMed ID: 15566282
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and antitumor activity of mechercharmycin A analogues.
Hernández D; Altuna M; Cuevas C; Aligué R; Albericio F; Alvarez M
J Med Chem; 2008 Sep; 51(18):5722-30. PubMed ID: 18763756
[TBL] [Abstract][Full Text] [Related]
27. 4- and 5-aroylindoles as novel classes of potent antitubulin agents.
Liou JP; Wu CY; Hsieh HP; Chang CY; Chen CM; Kuo CC; Chang JY
J Med Chem; 2007 Sep; 50(18):4548-52. PubMed ID: 17685504
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological evaluation of 4-arylcoumarin analogues of combretastatins.
Bailly C; Bal C; Barbier P; Combes S; Finet JP; Hildebrand MP; Peyrot V; Wattez N
J Med Chem; 2003 Dec; 46(25):5437-44. PubMed ID: 14640552
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and cytotoxic evaluation of combretafurazans.
Tron GC; Pagliai F; Del Grosso E; Genazzani AA; Sorba G
J Med Chem; 2005 May; 48(9):3260-8. PubMed ID: 15857132
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and biological evaluation of (-)-16-normethyldictyostatin: a potent analogue of (-)-dictyostatin.
Shin Y; Fournier JH; Balachandran R; Madiraju C; Raccor BS; Zhu G; Edler MC; Hamel E; Day BW; Curran DP
Org Lett; 2005 Jul; 7(14):2873-6. PubMed ID: 15987158
[TBL] [Abstract][Full Text] [Related]
31. 9-Benzylidene-naphtho[2,3-b]thiophen-4-ones as novel antimicrotubule agents-synthesis, antiproliferative activity, and inhibition of tubulin polymerization.
Zuse A; Schmidt P; Baasner S; Böhm KJ; Müller K; Gerlach M; Günther EG; Unger E; Prinz H
J Med Chem; 2006 Dec; 49(26):7816-25. PubMed ID: 17181164
[TBL] [Abstract][Full Text] [Related]
32. N-methylsansalvamide a peptide analogues. Potent new antitumor agents.
Liu S; Gu W; Lo D; Ding XZ; Ujiki M; Adrian TE; Soff GA; Silverman RB
J Med Chem; 2005 May; 48(10):3630-8. PubMed ID: 15887970
[TBL] [Abstract][Full Text] [Related]
33. Linear TMC-95-based proteasome inhibitors.
Basse N; Piguel S; Papapostolou D; Ferrier-Berthelot A; Richy N; Pagano M; Sarthou P; Sobczak-Thépot J; Reboud-Ravaux M; Vidal J
J Med Chem; 2007 Jun; 50(12):2842-50. PubMed ID: 17511440
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive study of sansalvamide A derivatives and their structure-activity relationships against drug-resistant colon cancer cell lines.
Otrubova K; Lushington G; Vander Velde D; McGuire KL; McAlpine SR
J Med Chem; 2008 Feb; 51(3):530-44. PubMed ID: 18186604
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and antitumor activity of cyclodepsipeptide zygosporamide and its analogues.
Wang Y; Zhang F; Zhang Y; Liu JO; Ma D
Bioorg Med Chem Lett; 2008 Aug; 18(15):4385-7. PubMed ID: 18606540
[TBL] [Abstract][Full Text] [Related]
36. B-ring-modified isocombretastatin A-4 analogues endowed with interesting anticancer activities.
Hamze A; Rasolofonjatovo E; Provot O; Mousset C; Veau D; Rodrigo J; Bignon J; Liu JM; Wdzieczak-Bakala J; Thoret S; Dubois J; Brion JD; Alami M
ChemMedChem; 2011 Dec; 6(12):2179-91. PubMed ID: 21990101
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological evaluation of cryptophycin analogs with substitution at C-6 (fragment C region).
Varie DL; Shih C; Hay DA; Andis SL; Corbett TH; Gossett LS; Janisse SK; Martinelli MJ; Moher ED; Schultz RM; Toth JE
Bioorg Med Chem Lett; 1999 Feb; 9(3):369-74. PubMed ID: 10091686
[TBL] [Abstract][Full Text] [Related]
38. An investigation into the cytotoxicity and mode of action of some novel N-alkyl-substituted isatins.
Vine KL; Locke JM; Ranson M; Pyne SG; Bremner JB
J Med Chem; 2007 Oct; 50(21):5109-17. PubMed ID: 17887662
[TBL] [Abstract][Full Text] [Related]
39. Tumor-cell-targeted methionine-enkephalin analogues containing unnatural amino acids: design, synthesis, and in vitro antitumor activity.
Horvat S; Mlinarić-Majerski K; Glavas-Obrovac L; Jakas A; Veljković J; Marczi S; Kragol G; Roscić M; Matković M; Milostić-Srb A
J Med Chem; 2006 Jun; 49(11):3136-42. PubMed ID: 16722632
[TBL] [Abstract][Full Text] [Related]
40. MPC-6827: a small-molecule inhibitor of microtubule formation that is not a substrate for multidrug resistance pumps.
Kasibhatla S; Baichwal V; Cai SX; Roth B; Skvortsova I; Skvortsov S; Lukas P; English NM; Sirisoma N; Drewe J; Pervin A; Tseng B; Carlson RO; Pleiman CM
Cancer Res; 2007 Jun; 67(12):5865-71. PubMed ID: 17575155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
